Pressure BioSciences, Inc. (OTCQB: PBIO) is a life sciences company that develops, markets, and sells proprietary laboratory instrumentation and associated consumables. SNNLive spoke with Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. at the SeeThruEquity Winter MicroCap Conference 2015 in New York City, NY.
Mr. Schumacher starts off with an update on the Company, where he describes Pressure Bio’s laboratory instruments. As he explains, “So when a scientist pulls out a protein from a cell, the scientist wants to study that protein, and to do that they have to dissolve it, they have to digest it... That’s a process that generally takes 24 hours. If you do that under pressure, you can do it in under an hour. That means we are speeding up research.” He goes on to discuss the Company’s target market for their proprietary patented pressure cycling technology, called PCT.
Mr. Schumacher then updates SNN with what’s happening at Pressure Bio, “We said last year when you and I last spoke… that we had developed a new system, a new pressure system, that we were going to bring out to the market… we started showing it last June, we put it in three places in November and December, and in 10 weeks, we got our first purchase order… in only 10 weeks, we had a major biotech company buy the new system!” He concludes by discussing what to expect from Pressure BioSciences in the coming year. For more information about Pressure BioSciences, Inc., please visit: www.PressureBioSciences.com
© 2017 Stock News Now
Supported by Superior Web Solutions